Journal article
Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes: The Diabetes Outcomes in Veterans Study
Diabetes care, Vol.25(10), pp.1744-1748
2002
DOI: 10.2337/diacare.25.10.1744
PMID: 12351471
Abstract
OBJECTIVE—To evaluate once- and twice-daily self-monitored blood glucose testing strategies in assessing glycemic control and detecting hypoglycemia or hyperglycemia in patients with stable insulin-treated type 2 diabetes.
RESEARCH DESIGN AND METHODS—Subjects with stable insulin-treated type 2 diabetes monitored blood glucose four times daily (prebreakfast, prelunch, predinner, and bedtime) for 8 weeks. We correlated mean blood glucose values with HbA1c measured after 8 weeks and determined the number of hypoglycemic (≤3.33 mmol/l) and hyperglycemic (≥22.20 mmol/l) readings captured at the various testing times.
RESULTS—A total of 150 subjects completed the monitoring period; their average age was 67 years, 90% were men, and the mean HbA1c at baseline was 8.0 ± 1.8%. The overall correlation of glucose testing and HbA1c was 0.79 (P < 0.0001). Mean blood glucose values for each of the four once-daily testing strategies were significantly correlated with HbA1c (r = 0.65–0.70, P < 0.0001), as were mean blood glucose values for each of the six twice-daily testing strategies (r = 0.73–0.75, P < 0.0001). The prebreakfast/prelunch measurements captured the largest proportion (63.6%) of the hypoglycemic readings, the predinner/bedtime measurements captured the largest proportion (66.2%) of hyperglycemic readings, and the prelunch/predinner measurements captured the largest proportion (57.7%) of all out-of-range readings.
CONCLUSIONS—Twice-daily testing strategies, particularly prelunch/predinner, effectively assess glycemic control and capture a substantial proportion of out-of-range readings. However, personal testing strategies will vary depending on an individual’s risk for hypoglycemia and hyperglycemia.
Details
- Title: Subtitle
- Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes: The Diabetes Outcomes in Veterans Study
- Creators
- Richard M HOFFMAN - Department of Medicine, New Mexico VA Health Care System, Albuquerque, New Mexico, United StatesJayendra H SHAH - Southern Arizona VAHealth Care System, Tucson, Arizona, United StatesChristopher S WENDEL - Southern Arizona VAHealth Care System, Tucson, Arizona, United StatesWilliam C DUCKWORTH - Department of Medicine, Carl T. Hayden VA Medical Center, Phoenix, Arizona, United StatesKaren D ADAM - Department of Medicine, New Mexico VA Health Care System, Albuquerque, New Mexico, United StatesSyed U BOKHARI - Department of Medicine, Carl T. Hayden VA Medical Center, Phoenix, Arizona, United StatesCheri DALTON - Southern Arizona VAHealth Care System, Tucson, Arizona, United StatesGlen H MURATA - Department of Medicine, New Mexico VA Health Care System, Albuquerque, New Mexico, United StatesDiabetes Outcome in Veterans Study
- Resource Type
- Journal article
- Publication Details
- Diabetes care, Vol.25(10), pp.1744-1748
- DOI
- 10.2337/diacare.25.10.1744
- PMID
- 12351471
- NLM abbreviation
- Diabetes Care
- ISSN
- 0149-5992
- eISSN
- 1935-5548
- Publisher
- American Diabetes Association
- Language
- English
- Date published
- 2002
- Academic Unit
- Epidemiology; General Internal Medicine; Internal Medicine
- Record Identifier
- 9984094757502771
Metrics
25 Record Views